Sonormed GmbH
Sonormed GmbH operates Meine Tinnitus App, a German DiGA-listed digital therapeutic that delivers a 10-week Tinnitus Counseling program to patients with subjective tinnitus, reimbursed by statutory health insurers on prescription and supplemented by direct private-pay purchase.
- Company typePrivate
- Founded2012
- HeadquartersHamburg, Germany
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Sonormed GmbH does
Sonormed GmbH is a Hamburg-based medical technology company founded in 2012 that operates in digital audiology through a single product, the Meine Tinnitus App. The app delivers a structured 10-week digital therapeutic based on the Tinnitus Counseling methodology for patients with subjective tinnitus, which the company notes accounts for approximately 99% of tinnitus cases. It is registered as a Class I CE-marked medical device and listed in the German BfArM DiGA directory (listing ID 01496).
The app is built as a mobile application for iOS and Android, with adaptive lesson composition driven by an initial patient questionnaire that targets the most burdensome co-occurring symptoms (sleep, emotional, hearing, concentration). Content is delivered across reading, audio, video, interactive games, and quizzes, and the app remains functional offline after initial registration and license activation.
The business model is primarily prescription-based: patients obtain a prescription from any physician or psychotherapist, submit it to their German statutory health insurer (gesetzliche Krankenkasse), receive a 16-digit activation code, and download the app — with the insurer reimbursing the company at the regulated DiGA price. A secondary channel via Digistore24 serves privately insured and self-paying patients. Distribution and customer service are handled operationally through a partnership with Infectopharm Digital Health, and the Avi Medical video consultation integration supports prescription access without an in-person visit.
Sonormed GmbH firmographics
Firmographics- Name
- Sonormed GmbH
- Legal name
- Sonormed GmbH
- Website
- https://tinnitracks.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sonormed GmbH operates Meine Tinnitus App, a German DiGA-listed digital therapeutic that delivers a 10-week Tinnitus Counseling program to patients with subjective tinnitus, reimbursed by statutory health insurers on prescription and supplemented by direct private-pay purchase.
- Ownership category
- akta.pro rank
Sonormed GmbH industry classification
Industry- Product category
- Digital Therapeutics / Digital Health Applications (DiGA)
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)
Keywords
Where Sonormed GmbH is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Markets served
Sonormed GmbH business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Statutory Health Insurance Reimbursement: Patients with German statutory (gesetzliche) health insurance receive the app at no cost when they have a valid prescription. The company bills the health insurer directly after the patient exchanges their prescription for an activation code. This is the primary revenue stream.
- Direct Purchase (Private Patients): Privately insured patients or those without statutory coverage can purchase the app directly via Digistore24. A PDF invoice is provided for submission to the private insurer for potential reimbursement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Statutory Health Insurance — 100% Covered |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Sonormed GmbH product offering
Product offeringCore offering
Sonormed GmbH develops and operates "Meine Tinnitus App," a CE-marked Class I medical device and prescription digital health application (DiGA) listed in the German BfArM directory (listing ID 01496). The app delivers a 10-week structured Tinnitus Counseling program for adults with subjective tinnitus, with adaptive multimedia lessons (reading, audio, video, interactive games, quizzes) personalized to each patient's most burdensome co-occurring symptoms. The app is fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, and is available via direct purchase through Digistore24 for privately insured patients.
Product overview
Sonormed GmbH operates as a digital health company offering a single core product: Meine Tinnitus App. This app-based digital health application (DiGA) delivers a structured 10-week therapy program grounded in Tinnitus Counseling methodology, providing personalized lessons adapted to individual patient symptoms. The product is available via prescription for statutory health insurance members (fully covered) or direct purchase for private insurance users.
Differentiator
Problem solved
Functional benefit
Brands
- Meine Tinnitus App: A digital tinnitus counseling app that provides interactive lessons for managing tinnitus. The app is registered as a Class 1 medical device and listed in the German DiGA (Digital Health Applications) directory. It offers personalized lessons addressing tinnitus-related symptoms such as sleep disturbances, emotional distress, hearing problems, and concentration deficits.
Products and services
- Meine Tinnitus App A digital health application (DiGA) for adult patients in Germany diagnosed with subjective tinnitus. Delivers a structured 10-week Tinnitus Counseling program of weekly lessons (60–90 minutes each) using adaptive multimedia content (readings, audio, video, interactive games, quizzes) personalized to the patient's most burdensome co-occurring symptoms (sleep disturbance, emotional distress, hearing problems, concentration deficits). Available fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, or via direct purchase through Digistore24 for privately insured patients.
Quantifiable outcome
- Clinically proven significant reduction in tinnitus burden within 10 weeks vs. non-users (p<0.001)
Companies that use Sonormed GmbH
Customer profileSegments1 record
Ideal customer profiles3 records
Sonormed GmbH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Sonormed GmbH partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Infectopharm Digital HealthcoreInfectopharm Digital Health is the company behind Meine Tinnitus App. It handles customer service (phone and email support), billing with health insurers, and overall product distribution. The app is branded and marketed as an 'innovative App von Infectopharm Digital Health'.
- Avi MedicalminorAvi Medical is a video consultation provider that offers patients a video appointment with a physician to obtain a prescription for Meine Tinnitus App. The consultation is free for statutorily insured patients. This partnership facilitates prescription access for patients without an in-person doctor visit.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Sonormed GmbH competitors and assessment
Company assessmentDirect peers
- Selfapy: German digital therapeutics company with multiple DiGA-listed products for mental health indications. Operates under the same DiGA regulatory and reimbursement framework as Sonormed, with analogous prescription-driven GTM and statutory-insurance billing — making it a directly comparable business model peer.
- Mindable Health: Munich-based DiGA company offering a reimbursed digital therapeutic for panic disorder and agoraphobia. Mirrors Sonormed's prescription-driven, statutory-insurance-reimbursed GTM and Class I/IIa SaMD regulatory pathway.
- Vivira Health Lab: Berlin-based DiGA company for non-specific back pain, operating on the same BfArM-listed, statutory-health-insurance-reimbursed digital therapeutics model. Closely comparable in distribution mechanics and target customer (chronic-condition patients on prescription).
- Cara Care: Berlin-based DiGA for irritable bowel syndrome that uses the same prescription → activation code → app download flow as Meine Tinnitus App. Direct competitor in the German DiGA category with overlapping regulatory and commercial mechanics.
Broad incumbents
- Sonova: Global hearing-aid leader (Phonak, Unitron) that bundles tinnitus therapy features into its hearing-aid companion apps. Operates in the same audiology end-market as Sonormed but with hardware as the primary revenue driver — a broader incumbent with overlapping patient populations.
- Demant: Danish hearing-aid group behind Oticon, Bernafon, Sonic, and Philips Hearing Solutions. Offers tinnitus management features in its hearing-aid ecosystem, competing with Sonormed for the same patient population but from a hardware-centric, broader-portfolio position.
- GN Audio (GN Hearing): Owner of ReSound and Beltone hearing aids, with a dedicated tinnitus app (ReSound Tinnitus Relief). A broad incumbent in audiology that overlaps directly with Sonormed's target patient and indication.
- Starkey Hearing Technologies: US-based hearing-aid major that ships tinnitus therapy content within its companion app portfolio. Competes for the same tinnitus patient population, bundled into a hardware-plus-software offering.
Emerging players
- Akili Interactive: US-listed digital therapeutics company (EndeavorRx for ADHD) and one of the few pure-play publicly traded DTx peers. Comparable as a clinically validated, prescription-grade software therapeutic, though operating in a different indication and reimbursement system.
- AudioCure: Swiss/German clinical-stage biopharma developing pharmacological treatments for hearing loss and tinnitus. An emerging player addressing the same underlying condition through a different modality (drug rather than digital therapeutic), making it a useful therapeutic-area comparable for market sizing.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Sonormed GmbH social profiles
Digital presenceSonormed GmbH compliance and trust
Trust signalCompliance1 record
Sonormed GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sonormed GmbH leadership team
Management profileNumber of profiles
Profiles1 record
Sonormed GmbH funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sonormed GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sonormed GmbH
What does Sonormed GmbH do?
Sonormed GmbH develops and operates "Meine Tinnitus App," a CE-marked Class I medical device and prescription digital health application (DiGA) listed in the German BfArM directory (listing ID 01496). The app delivers a 10-week structured Tinnitus Counseling program for adults with subjective tinnitus, with adaptive multimedia lessons (reading, audio, video, interactive games, quizzes) personalized to each patient's most burdensome co-occurring symptoms. The app is fully reimbursed by German statutory health insurance upon physician or psychotherapist prescription, and is available via direct purchase through Digistore24 for privately insured patients.
Is Sonormed GmbH a public or private company?
Sonormed GmbH is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sonormed GmbH founded?
Sonormed GmbH was founded in 2012. It employs 1 to 10 people.
Where is Sonormed GmbH based?
Sonormed GmbH is headquartered in Hamburg, Germany, in the Europe region.
How does Sonormed GmbH make money?
Two revenue lines are on record. Statutory Health Insurance Reimbursement is the primary driver. The others are direct Purchase (Private Patients).
Who are Sonormed GmbH's main competitors?
Direct peers on record are Selfapy, Mindable Health, Vivira Health Lab and Cara Care. Broad incumbents are Sonova, Demant, GN Audio (GN Hearing) and Starkey Hearing Technologies. Emerging players are Akili Interactive and AudioCure.
Does Sonormed GmbH have an API?
No public API is recorded for Sonormed GmbH.
What industry is Sonormed GmbH in?
Sonormed GmbH's product category is Digital Therapeutics / Digital Health Applications (DiGA). Its primary akta.pro industry code is HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 62134 and its SIC code is 8090.